910394534	910394534	CD	B-NP	O
|	|	NN	I-NP	O
AIGH	AIGH	NN	I-NP	O
|	|	NN	I-NP	O
79092196	79092196	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6107474	6107474	CD	B-NP	O
|	|	CC	I-NP	O
8/25/2006	8/25/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/10/2006	1/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/29/2006	4/29/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
CHEYNE	CHEYNE	NN	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NN	B-NP	O
689-07-33-4	689-07-33-4	CD	I-NP	O
Gundron	Gundron	NNP	I-NP	O
Fernrappe	Fernrappe	NNP	I-NP	O
Hwy	Hwy	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/20/06	8/20/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WITTRY	WITTRY	NNP	B-NP	O
,	,	,	O	O
BENTON	BENTON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
CALTRATE	CALTRATE	NN	B-NP	O
+	+	SYM	O	O
D	D	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
DOXEPIN	DOXEPIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BEDTIME	BEDTIME	NN	I-NP	O
Starting	Start	VBG	B-VP	O
STAT	STAT	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
9/21	9/21	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
FEXOFENADINE	FEXOFENADINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

PROCTOSOL	PROCTOSOL	NN	B-NP	O
HC	HC	NN	I-NP	O
2.5	2.5	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCORTISONE	HYDROCORTISONE	NN	I-NP	O
2.5	2.5	CD	B-NP	O
%	%	NN	I-NP	O
-	-	HYPH	B-NP	O
RECTAL	RECTAL	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CREAM	CREAM	NNP	I-NP	O
PR	PR	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Constipation	Constipation	NNP	B-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
LEANARD	LEANARD	NNP	B-NP	O
,	,	,	O	O
KENNY	KENNY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRIAMTERENE	TRIAMTERENE	NNP	B-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
SKELAXIN	SKELAXIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METAXALONE	METAXALONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
400-800	400-800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Other	Other	NNP	B-NP	O
:	:	:	O	O
muscle	muscle	NN	B-NP	O
spasms	spasm	NNS	I-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
BAND	BAND	NN	B-NP	B-protein
,	,	,	O	O
GARRETT	GARRETT	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
826253074	826253074	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
LURY	LURY	NNP	B-NP	O
,	,	,	O	O
OLIVER	OLIVER	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
RUVALCABA	RUVALCABA	NNP	B-NP	O
,	,	,	O	O
MARION	MARION	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
MAXZIDE-25	MAXZIDE-25	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRIAMTERENE	TRIAMTERENE	NN	I-NP	O
37.5	37.5	CD	I-NP	O
MG/HYDROCHLOROTHI	MG/HYDROCHLOROTHI	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
RUSTEN	RUSTEN	NN	B-NP	O
,	,	,	O	O
PRINCE	PRINCE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
405861568	405861568	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRIAMTERENE	TRIAMTERENE	NNP	B-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
CESARI	CESARI	NNP	B-NP	O
,	,	,	O	O
DARNELL	DARNELL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
780796072	780796072	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRIAMTERENE	TRIAMTERENE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
BRADAC	BRADAC	NN	B-NP	O
,	,	,	O	O
EDMOND	EDMOND	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
374114249	374114249	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRIAMTERENE	TRIAMTERENE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
request	request	NN	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
BRAGE	BRAGE	NN	B-NP	O
,	,	,	O	O
IRWIN	IRWIN	NNP	B-NP	B-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
MONDAY/WEDNESDAY/FRIDAY	MONDAY/WEDNESDAY/FRIDAY	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
DEEB	DEEB	NN	B-NP	B-protein
,	,	,	O	O
RODRIGO	RODRIGO	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
058909343	058909343	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
qdaily	qdaily	RB	B-ADVP	O
Tues	Tues	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Sat	Sat	NNP	B-NP	B-protein
,	,	,	O	O
Sun	Sun	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
FALARDEAU	FALARDEAU	NN	B-NP	O
,	,	,	O	O
MILES	MILES	NNS	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
058909343	058909343	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Caracciola	Caracciola	NNP	I-NP	O
office	office	NN	I-NP	O
at	at	IN	B-PP	O
-LRB-	-LRB-	SYM	B-NP	O
983	983	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
961-1934	961-1934	CD	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
available	available	JJ	I-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/7/06	2/7/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Wechselblatt	Wechselblatt	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
rule	rule	VB	B-VP	O
out	out	RP	B-PRT	O
MI/epistaxis	MI/epistaxis	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
epistaxis	epistaxis	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
hyperchol	hyperchol	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
6/23	6/23	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
panic	panic	NN	I-NP	O
d/o	d/o	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
panic	panic	NN	I-NP	O
attacks	attack	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ECHO	ECHO	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
nose	nose	NN	B-NP	O
bleeds	bleed	NNS	I-NP	O
,	,	,	O	O
c/p	c/p	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
y/o	y/o	NN	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
DVT/PE	DVT/PE	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
1998	1998	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
HTN	HTN	NN	I-NP	B-protein
presenting	present	VBG	B-VP	O
today	today	NN	B-NP	O
with	with	IN	B-PP	O
nosebleeds	nosebleed	NNS	B-NP	O
and	and	CC	O	O
c/p	c/p	NN	B-NP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
one	one	CD	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
statred	statre	VBD	B-VP	O
having	have	VBG	I-VP	O
nosebleeds	nosebleed	NNS	B-NP	O
yesterday	yesterday	NN	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
large	large	JJ	B-NP	O
clots	clot	NNS	I-NP	O
coming	come	VBG	B-VP	O
out	out	IN	B-ADVP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_type
nostrils	nostril	NNS	I-NP	I-cell_type
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
more	more	JJR	I-NP	O
episodes	episode	NNS	I-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
nose	nose	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
mouth/coughing	mouth/coughing	NN	I-NP	O
up	up	RP	B-PRT	O
blood	blood	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
some	some	DT	B-NP	O
right	right	JJ	I-NP	O
sided	sided	JJ	I-NP	O
c/p	c/p	NN	I-NP	O
that	that	WDT	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
back	back	NN	I-NP	O
and	and	CC	I-NP	O
R-shoulder	R-shoulder	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
palpitation	palpitation	NN	B-NP	O
sor	sor	NN	I-NP	O
sweating	sweating	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
felt	feel	VBD	B-VP	O
c/p	c/p	NN	B-NP	O
was	be	VBD	B-VP	O
2/2	2/2	CD	B-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
feeling	feeling	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
die	die	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
nosebleeds	nosebleed	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cold	cold	JJ	I-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
and	and	CC	O	O
took	take	VBD	B-VP	O
Nyquil	Nyquil	NNP	B-NP	O
,	,	,	O	O
,	,	,	O	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
antihistamine	antihistamine	NN	B-NP	O
use	use	NN	I-NP	O
or	or	CC	O	O
dry	dry	JJ	B-NP	O
nose	nose	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
recent	recent	JJ	I-NP	O
trauma	trauma	NN	I-NP	O
or	or	CC	I-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

SHe	SHe	NNP	B-NP	O
did	do	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
feel	feel	VB	B-VP	O
dizzy	dizzy	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nosebleeding	nosebleeding	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
nosebleeds	nosebleed	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
s/p	s/p	NN	I-NP	O
cauterization	cauterization	NN	I-NP	O
.	.	.	O	O

ER	ER	NN	B-NP	B-protein
:	:	:	O	O
BP	BP	NN	B-NP	O
201/109	201/109	CD	I-NP	O
with	with	IN	B-PP	O
HR-86	HR-86	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
NTG	NTG	NN	B-NP	B-protein
and	and	CC	I-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
;	;	:	O	O
EKG	EKG	NN	B-NP	O
showed	show	VBD	B-VP	O
inverted	invert	VBN	I-VP	O
T	T	NN	B-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
*************************************************	*************************************************	SYM	B-NP	O
ROS	ROS	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
sob	sob	NN	I-NP	B-protein
,	,	,	O	O
blurry	blurry	NN	B-NP	O
vision	vision	NN	I-NP	O
,	,	,	O	O
blackouts	blackout	NNS	B-NP	O
,	,	,	O	O
hematuria/dysuria	hematuria/dysuria	NN	B-NP	O
,	,	,	O	O
hematochezia	hematochezia	NN	B-NP	O
;	;	:	O	O
pos	po	NNS	B-NP	O
bleeding	bleed	VBG	B-VP	O
gums	gum	NNS	B-NP	O
and	and	CC	O	O
easy	easy	JJ	B-NP	O
bruising	bruising	NN	I-NP	O
since	since	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
tx	tx	NN	I-NP	O
*************************************************	*************************************************	SYM	B-NP	O
Allergies	Allergy	NNPS	I-NP	O
:	:	:	O	O
nkda	nkda	NN	B-NP	O
*************************************************	*************************************************	SYM	B-NP	O
Medications	Medication	NNS	I-NP	O
:	:	:	O	O
Doxepin	Doxepin	NN	B-NP	O
HCl	HCl	NN	I-NP	O
20mg	20mg	NN	I-NP	O
qHS	qHS	NN	I-NP	O
,	,	,	O	O
Maxzide	Maxzide	NN	B-NP	B-protein
37.5	37.5	CD	I-NP	I-protein
/	/	SYM	I-NP	O
25	25	CD	I-NP	O
qD	qD	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
mwf	mwf	NN	I-NP	O
,	,	,	O	O
2.5	2.5	CD	B-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
tues	tue	NNS	I-NP	O
,	,	,	O	O
thurs	thur	NNS	B-NP	O
,	,	,	O	O
sat	sat	NN	B-NP	O
,	,	,	O	O
sun	sun	NN	B-NP	O
;	;	:	O	O
Simvastatin	Simvastatin	NN	B-NP	O
40	40	CD	B-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
Calcium	Calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
650	650	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
skelaxin	skelaxin	NN	B-NP	O
400-800	400-800	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
MVT	MVT	NN	B-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
prilosec	prilosec	VBP	B-VP	O
20	20	CD	B-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
proctosol-hc	proctosol-hc	NN	B-NP	O
cream	cream	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
allegra	allegra	NN	B-NP	O
60	60	CD	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
citalopram	citalopram	NN	B-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
**************************************************	**************************************************	SYM	O	O
PMH/PSH	PMH/PSH	NN	B-NP	O
:	:	:	O	O
end	end	VB	B-VP	O
stage	stage	NN	B-NP	O
rigid	rigid	JJ	I-NP	O
pes	pe	NNS	I-NP	O
planovalgus	planovalgus	NN	I-NP	O
deformity	deformity	NN	I-NP	O
,	,	,	O	O
PE	PE	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
1998	1998	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
,	,	,	O	O
menorrhagia	menorrhagia	NN	B-NP	O
hx	hx	NN	I-NP	O
s/p	s/p	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
and	and	CC	O	O
ex	ex	NN	B-NP	O
lap	lap	NN	I-NP	O
,	,	,	O	O
mva	mva	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
1999	1999	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
gerd	gerd	NN	B-NP	O
,	,	,	O	O
obestiy	obestiy	NN	B-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
miscarriages	miscarriage	NNS	I-NP	O
**************************************************	**************************************************	SYM	B-NP	O
Soc	Soc	NN	I-NP	O
hx	hx	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
etoh	etoh	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
drugs	drug	NNS	B-NP	O
;	;	:	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
schoolteacher	schoolteacher	NN	I-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
husband	husband	NN	B-NP	O
and	and	CC	I-NP	O
son	son	NN	I-NP	O
*************************************************	*************************************************	SYM	B-NP	O
Fam	Fam	NN	I-NP	O
hx	hx	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
hypercoagulability	hypercoagulability	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
daughter	daughter	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
daughter	daughter	NN	I-NP	O
had	have	VBD	B-VP	O
PE	PE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
**************************************************	**************************************************	SYM	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
98.5	98.5	CD	B-NP	O
/	/	SYM	I-NP	O
801	801	CD	I-NP	O
/	/	SYM	I-NP	O
160/80	160/80	CD	I-NP	O
/	/	SYM	I-NP	O
18	18	CD	I-NP	O
/	/	SYM	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2L	2L	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
nad	nad	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
perrla	perrla	NN	B-NP	O
;	;	:	O	O
petechiae	petechiae	FW	B-NP	O
on	on	IN	B-PP	O
tip	tip	NN	B-NP	O
of	of	IN	B-PP	O
tongue	tongue	NN	B-NP	O
;	;	:	O	O
nostrils	nostril	NNS	B-NP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
scabbing	scabbing	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
;	;	:	O	O
throat	throat	NN	B-NP	O
noneryth	noneryth	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
throat	throat	NN	I-NP	O
petechiae	petechiae	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
cta	cta	NN	B-NP	O
b/l	b/l	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
c/r/r	c/r/r	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
rrr	rrr	NN	B-NP	O
;	;	:	O	O
ns1/s2	ns1/s2	NN	B-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	O
;	;	:	O	O
DP	DP	NN	B-NP	O
's	's	POS	B-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
b/l	b/l	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
ntnd	ntnd	NN	I-NP	O
;	;	:	O	O
pos	po	NNS	B-NP	O
bs	b	NNS	I-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
c/c	c/c	NN	I-NP	B-DNA
;	;	:	O	I-DNA
mild	mild	JJ	B-NP	I-DNA
non-pitting	non-pitting	JJ	I-NP	I-DNA
edema	edema	NN	I-NP	I-DNA
L	L	NN	I-NP	I-DNA
>	>	SYM	B-VP	I-DNA
R	R	NN	B-NP	I-DNA
lower	low	JJR	B-NP	I-DNA
pretibial	pretibial	JJ	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
scaling	scaling	NN	B-NP	O
and	and	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
;	;	:	O	O
palpable	palpable	JJ	B-NP	O
cord	cord	NN	I-NP	O
in	in	IN	B-PP	O
R	R	NN	B-NP	B-protein
ankle	ankle	NN	I-NP	I-protein
Neuro	Neuro	NN	I-NP	I-protein
:	:	:	O	O
a	a	DT	B-NP	O
and	and	CC	I-NP	O
o	o	NN	I-NP	O
;	;	:	O	O
cn	cn	NN	B-NP	O
2-12	2-12	CD	I-NP	O
intact	intact	JJ	I-NP	O
;	;	:	O	O
dtr	dtr	NN	B-NP	O
's	's	POS	B-NP	O
2	2	CD	I-NP	O
+	+	SYM	B-VP	O
in	in	IN	B-PP	O
ue/le	ue/le	JJ	B-NP	O
b/l	b/l	NN	I-NP	O
;	;	:	O	O
babinksy	babinksy	NN	B-NP	O
's	's	POS	B-NP	O
downgoing	downgoe	VBG	I-NP	O
b/l	b/l	NN	I-NP	O
Skin	Skin	NNP	I-NP	O
:	:	:	O	O
scaling	scale	VBG	B-VP	O
in	in	IN	B-PP	O
pretibial	pretibial	JJ	B-NP	O
areas	area	NNS	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
bruising	bruise	VBG	I-NP	O
*************************************************	*************************************************	SYM	I-NP	B-protein
Labs	Lab	NNPS	I-NP	I-protein
:	:	:	O	O
Tn	Tn	NN	B-NP	B-protein
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.10	0.10	CD	B-NP	O
,	,	,	O	O
d	d	NN	B-NP	O
dimer	dimer	NN	I-NP	O
218	218	CD	I-NP	O
;	;	:	O	O
INR-2	INR-2	NN	B-NP	O
.6	.6	NN	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	B-cell_line
38.3	38.3	CD	I-NP	I-cell_line
-LRB-	-LRB-	:	O	O
MCV-88	MCV-88	NN	B-NP	O
.9	.9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
*************************************************	*************************************************	SYM	B-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
EKG-T	EKG-T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
*************************************************	*************************************************	SYM	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
y/o	y/o	NN	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	O
and	and	CC	I-NP	O
menorrhagia	menorrhagia	NN	I-NP	O
s/p	s/p	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
epistaxis	epistaxis	NN	B-NP	O
and	and	CC	I-NP	O
c/p	c/p	NN	I-NP	O
.	.	.	O	O

1-Epistaxis	1-Epistaxis	NN	B-NP	O
:	:	:	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
anti-coagulation	anti-coagulation	JJ	B-NP	B-protein
vs	v	NNS	I-NP	I-protein
underlying	underlie	VBG	B-VP	O
blood	blood	NN	B-NP	O
dyscrasia	dyscrasia	NN	I-NP	O
vs	vs	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
rhinitis	rhinitis	NN	I-NP	O
vs	vs	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
previous	previous	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
possible	possible	JJ	I-NP	O
AVM	AVM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
vs	vs	CC	O	O
longstanding	longstanding	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
vs	vs	IN	B-PP	O
tumor	tumor	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
another	another	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
nosebleed/clot	nosebleed/clot	NN	B-NP	O
while	while	IN	B-SBAR	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
uncontrollable	uncontrollable	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
tamponade	tamponade	VB	I-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
nares	nare	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
menorrhagia	menorrhagia	NN	B-NP	O
,	,	,	O	O
previous	previous	JJ	B-NP	O
DVT/PE	DVT/PE	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
family	family	NN	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
different	different	JJ	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
hyper/hypocoagulability	hyper/hypocoagulability	NN	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
pt	pt	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
platelet	platelet	NN	I-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
von	von	NN	B-NP	O
willebrand	willebrand	NN	I-NP	O
's	's	POS	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
hemophilia	hemophilia	NN	B-NP	O
,	,	,	O	O
osler-weber-rendu	osler-weber-rendu	JJ	B-NP	O
d/o	d/o	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
also	also	RB	B-ADVP	O
important	important	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
nasal	nasal	JJ	I-NP	O
AVM	AVM	NN	I-NP	O
or	or	CC	O	O
?	?	.	O	O

tumor	tumor	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
low	low	JJ	I-NP	O
likelihood	likelihood	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
as	as	IN	B-SBAR	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
forming	form	VBG	B-VP	O
DVT	DVT	NNP	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
HCTZ/triamterene	HCTZ/triamterene	NN	B-NP	B-DNA
and	and	CC	I-NP	O
captopril	captopril	NN	I-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
control	control	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
BP	BP	NN	I-NP	I-protein
dropped	drop	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
and	and	CC	I-NP	O
HR	HR	NN	I-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
40	40	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
thus	thus	RB	O	O
her	her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
needed	need	VBD	B-VP	O
captopril	captopril	NN	B-NP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
BP	BP	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
will	will	MD	B-VP	O
D/C	D/C	VB	I-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
2.5	2.5	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
compliance	compliance	NN	B-NP	O
and	and	CC	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
importance	importance	NN	B-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
compliant	compliant	JJ	B-ADJP	O
on	on	IN	B-PP	O
medications	medication	NNS	B-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
very	very	RB	B-NP	O
high	high	JJ	I-NP	O
BP	BP	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

2-chest	2-chest	JJ	B-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
ACS	ACS	NN	B-NP	O
vs	vs	IN	B-PP	O
PE	PE	NNP	B-NP	O
vs	vs	IN	B-PP	O
GERD	GERD	NNP	B-NP	O
vs	vs	IN	B-PP	O
panic	panic	JJ	B-NP	O
attacks	attack	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
several	several	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
her	her	PRP$	B-NP	O
CE	CE	NN	I-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
cycled	cycle	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
Echo	Echo	NNP	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
EF	EF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
mild	mild	JJ	I-NP	O
MR.	MR.	NNP	I-NP	O
Pt	Pt	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
official	official	JJ	I-NP	O
DM	DM	NN	I-NP	O
dx	dx	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
glucose	glucose	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
a	a	DT	B-NP	O
HbA1C	HbA1C	NN	I-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
obtained	obtain	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
fasting	fasting	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
profile	profile	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
take	take	VB	B-VP	O
her	her	PRP$	B-NP	O
statins	statin	NNS	I-NP	O
regularly	regularly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
palpable	palpable	JJ	B-NP	O
cords	cord	NNS	I-NP	O
and	and	CC	O	O
calf	calf	NN	B-NP	B-protein
tenderness	tenderness	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
L	L	NN	I-NP	I-protein
>	>	SYM	B-NP	I-protein
R	R	NN	I-NP	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
,	,	,	O	O
so	so	IN	O	O
LENI	LENI	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
the	the	DT	B-NP	O
c/p	c/p	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
esophageal	esophageal	JJ	I-NP	O
spasm	spasm	NN	I-NP	O
or	or	CC	I-NP	O
GERD	GERD	NN	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
back	back	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	NNS	I-NP	O
having	have	VBG	B-VP	O
had	have	VBD	I-VP	O
spicy	spicy	NN	B-NP	O
foods	food	NNS	I-NP	O
or	or	CC	O	O
nausea/vomiting	nausea/vomite	VBG	B-VP	O
before	before	IN	B-SBAR	O
the	the	DT	B-NP	O
episodes	episode	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
sternum	sternum	NN	I-NP	O
and	and	CC	I-NP	O
L	L	NN	I-NP	O
ribcage	ribcage	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
c/p	c/p	NN	B-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
herself	herself	PRP	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
daughters	daughter	NNS	I-NP	O
and	and	CC	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
die	die	VB	I-VP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
stressed	stress	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
nosebleeding	nosebleeding	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
caused	cause	VBN	I-VP	O
her	her	PRP$	B-NP	O
c/p	c/p	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

3-Fibromyalgia	3-Fibromyalgia	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

4-FEN	4-FEN	NN	B-NP	O
:	:	:	O	O
IVF	IVF	NN	B-NP	B-protein
were	be	VBD	B-VP	O
avoided	avoid	VBN	I-VP	O
given	give	VBN	B-PP	O
high	high	JJ	B-NP	O
BP	BP	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
K	K	NN	I-NP	O
and	and	CC	I-NP	O
Mag	Mag	NN	I-NP	B-protein
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
choles/fat	choles/fat	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
salt	salt	NN	I-NP	O
added	add	VBD	B-VP	O
diet	diet	NN	B-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
easily	easily	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
not	not	RB	B-VP	O
using	use	VBG	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
regularly	regularly	RB	B-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
take	take	VBP	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
regularly	regularly	RB	B-ADVP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
as	as	IN	B-PP	O
uncontrolled	uncontrolled	JJ	B-NP	O
high	high	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
can	can	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
kidney	kidney	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
eye	eye	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
must	must	MD	B-VP	O
also	also	RB	I-VP	O
watch	watch	VB	I-VP	O
your	your	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
eat	eat	VB	B-VP	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	JJ	I-NP	O
foods	food	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
added	add	VBN	I-NP	O
sodium	sodium	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
can	can	MD	B-VP	O
worsen	worsen	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	O	O
even	even	RB	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
must	must	MD	B-VP	O
also	also	RB	I-VP	O
continue	continue	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
regularly	regularly	RB	B-ADVP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
as	as	IN	B-PP	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
forming	form	VBG	B-VP	O
blood	blood	NN	B-NP	O
clots	clot	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
come	come	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
continued	continue	VBN	I-VP	O
uncontrolled	uncontrolled	JJ	B-NP	O
nose	nose	NN	I-NP	O
bleeds	bleed	NNS	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
uncontrollable	uncontrollable	JJ	I-NP	O
headaches	headache	NNS	I-NP	O
,	,	,	O	O
fainting	faint	VBG	B-VP	O
spells	spell	NNS	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
HGBA1C	HGBA1C	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
lipid	lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

We	We	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
pharmacologic	pharmacologic	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PURSIFULL	PURSIFULL	NNP	B-NP	O
,	,	,	O	O
LINCOLN	LINCOLN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PN70	PN70	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/20/06	8/20/06	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
37	37	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

